19-54240559-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_024318.5(LILRA6):c.973G>A(p.Val325Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00193 in 148,528 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024318.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LILRA6 | NM_024318.5 | c.973G>A | p.Val325Ile | missense_variant | 6/8 | NP_077294.3 | ||
LILRA6 | NR_104098.2 | n.926G>A | non_coding_transcript_exon_variant | 6/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LILRA6 | ENST00000396365.6 | c.973G>A | p.Val325Ile | missense_variant | 6/8 | 1 | ENSP00000379651.2 |
Frequencies
GnomAD3 genomes AF: 0.00193 AC: 287AN: 148406Hom.: 0 Cov.: 39
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00295 AC: 4024AN: 1365628Hom.: 1 Cov.: 139 AF XY: 0.00286 AC XY: 1915AN XY: 670464
GnomAD4 genome AF: 0.00193 AC: 287AN: 148528Hom.: 0 Cov.: 39 AF XY: 0.00175 AC XY: 127AN XY: 72386
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2021 | The c.973G>A (p.V325I) alteration is located in exon 6 (coding exon 6) of the LILRA6 gene. This alteration results from a G to A substitution at nucleotide position 973, causing the valine (V) at amino acid position 325 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at